Risk Assessment and Screening Toolkit to Detect Familial, Hereditary, and Early Onset Colorectal Cancer – June 19, 2018
This webinar introduced a new NCCRT resource for primary care providers, Risk Assessment and Screening Toolkit to Detect Familial, Hereditary and Early Onset Colorectal Cancer. The new toolkit aims to improve the ability of primary care clinicians to systematically collect, document, and act on a family history of CRC and adenomas polyps, while also educating clinicians on the need for more timely diagnostic testing for young adults who present with alarm signs or symptoms of CRC and ensuring that those patients receive a proper diagnostic work up. Speakers include:
- Emily Edelman, MS, CGC, Associate Director, Clinical & Continuing Education, The Jackson Laboratory;
- Dennis Ahnen, MD, Professor Emeritus, University of Colorado School of Medicine, NCCRT Steering Committee, NCCRT Co-Chair Family History and Early Age Onset CRC Task Group;
- Paul Schroy, MD, MPH, Professor of Medicine, Boston University School of Medicine, NCCRT Co-Chair Family History and Early Age Onset CRC Task Group;
- Thomas Weber, MD, Director of Surgical Oncology, Northwest Region at Northwell Health, NCCRT Chair Emeritus, NCCRT Co-Chair Family History and Early Age Onset CRC Task Group.
Explore More
2024 National Colorectal Cancer Awareness Month Webcast
The 2024 National Webcast celebrated national achievements and to hear the latest state of the field updates that inform the ACS NCCRT's work.
2023 Lead Time Messaging Guidebook
This Guidebook is intended to provide you with information and tools to motivate individuals at average and heightened risk for CRC to discuss screening prior to the recommended screening age. Our belief is that this will increase the likelihood that they will prioritize getting screened on-time for CRC.
Tailoring Colorectal Cancer Screening Messaging: A Practical Coalition Guide
This step-by-step guide is targeted at coalitions who are looking to make highly effective campaigns to increase colorectal cancer (CRC) screening rates in their communities, especially for those hardest to reach, illustrated by case studies.